The treatment of nonsaturating, neutralizing antibody-poliovirus complexes with papain generally led to the loss of viral neutralization and to the loss of the neutralization-associated change in the isoelectric point (pl) of the virion. Subsequent treatment with anti-immunoglobulin G antibodies restored the neutralization of the virus and the alteration of the viral pl. It appears that, under nonsaturating conditions, poliovirus neutralization by an antibody is dependent upon the ability of the antibody to bivalently attach to the virion. Exceptions are monospecific neutralizing antibodies with an affinity for capsid protein VP3.
In a recent study on the functional basis of antibody-dependent poliovirus neutralization, we examined seven anti-poliovirus type 1-monospecific antibodies for their role in the inhibition of viral infectivity (4) . Each of these antibodies binds to a unique epitope which is functionally independent of the epitopes to which the remaining antibodies bind. Six of the antibodies are monoclonal and attach to epitopes located on the VP1 structural protein (3, 3a, 4) . The remaining antibody, anti-VP4/VP3, was obtained from a rabbit which had been inoculated with the purified structural protein VP4. This serum contains a monospecific population of antibodies which neutralize by binding to a single site on the VP3 structural protein of the intact virion (2) .
Each of the seven monospecific neutralizing antibodies can significantly inhibit (>99%) the infectivity of poliovirus type 1 upon attachment of as few as four antibody molecules per virion (4) . In fact, Icenogle et al. (4a) have presented evidence that a minimum of four immunoglobulin G (IgG) molecules are required to neutralize the poliovirus virion, a study that was carried out with a single monoclonal antibody. Under nonsaturating conditions, six of the seven antibodies studied by us fail to inhibit either viral attachment or penetration into the host cell (4). (One monoclonal antibody appears to inhibit viral attachment.) Despite uptake, viral macromolecular synthesis does not occur. It appears that the block to viral replication is related to a neutralizing antibody-dependent alteration in the structural conformation of the virion. Each of the six monoclonal antibodies, when bound under nonsaturating conditions, alters the isoelectric point (pl) of the intact virion from 7.0 to ca. 3.5 (4), an observation in agreement with that reported previously in studies with hyperimmune sera (5) . An antibody which binds to the virion, but that does not neutralize it, has no effect on the pl of the virion. Hence, viral neutralization may be mediated by antibodies that interact with capsid protein VP1 through a mechanism of virion conformational change that could, in turn, inhibit the uncoating and subsequent expression of the viral RNA. Surprisingly, neutralization mediated by the monospecific anti-VP4/VP3 activity fails to change the viral pl. These antibodies have an affinity for an epitope on VP3 and may, therefore, neutralize by a unique mechanism (4). In this communication, we report experiments that will help to further elucidate the mechanism(s) of antibodydependent poliovirus neutralization. Finally, the effect of papain on neutralization by nonsaturating amounts of anti-VP4/VP3 antibodies was tested. Unlike the results obtained with the monoclonal antibodies, anti-VP4/VP3 F(ab) fragments were found to be capable of neutralizing the virus even under non saturating conditions ( Table 1 ). The observation supported the view that the anti-VP4/VP3 activity neutralizes poliovirus by a mechanism different from that employed by the monoclonal antibodies which bind to sites on VP1.
If the correlations among the antibody-induced virion conformational change, the change in the pl, and the antibody-induced viral neutralization are valid, the treatment of virus-antibody complexes with papain should lead to a restoration of the original conformation and pl of the virion. The experiments reported in Fig. 1 and Table 2 show that this was the case. The reacti- of the untreated virion. Subsequent treatment of the virion-F(ab) fragment complexes with goat anti-mouse IgG led, again, to a change in the vinon pI to ca. 3.5 (Table 2) . This is identical to the pl change seen when the virion was treated with intact neutralizing antibody.
As mentioned before, treatment of the Mahoney strain of virus with 1 BA 12-1 neither neutralizes the virion nor alters its pI (4). It was found that the induction of neutralization by bivalent attachment with IgG was associated with a change in pl to 3.5 ( Table 2) . At this pI a poliovirion had lost, in all cases tested, its ability to initiate an infectious cycle.
The observations reported in this note strongly support the view of antibody-dependent poliovirus neutralization first proposed by Mandel (6) may be responsible for the loss of viral infectivity after viral penetration. Furthermore, it now seems that the apparent conformational change requires the bivalent attachment of the neutralizing antibodies to the virion. It is not clear, however, whether bivalent attachment per se will lead to conformational change. For example, polyclonal anti-VP1 antibodies bind to and precipitate virions, but they do not induce a change in the pl (4) . It remains to be seen whether any of the antibodies in the anti-VP1 serum can bind bivalently to the surface of the vinron.
Finally, it should be noted again that we have identified at least one exception to the proposed rule of bivalent attachment, and this is the anti-VP4/VP3 neutralizing activity. With this monospecific antibody population, the bivalent attachment of antibody molecules and the decrease in the pl of the virion appear not to be essential for neutralization. We have recently obtained evidence that the anti-VP4/VP3 neutralizing antibodies bind to a specific region within VP3 (E. A. Emini, B. A. Jameson, and E. Wimmer, unpublished data). Thus, the mechanism(s) of antibody-mediated poliovirus neutralization may depend upon which of the capsid polypeptides of the virion is involved in antibody binding.
